Introduction: Sentinel lymphadenectomy for patients with clinical stage I melanoma

Journal of Surgical Oncology

Volumn 66, Issue 4, 1997, Pages 267-269

  Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; CANCER STAGING; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; PATHOLOGY; SCINTISCANNING; SKIN TUMOR; STAINING;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; SKIN NEOPLASMS; STAINING AND LABELING;

EID: 0031307337     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199712)66:4<267::AID-JSO9>3.0.CO;2-9     Document Type: Article

References (21)

1. Balch CM, Soong S-J, Murad TM, Ingalls AL, Maddox WA: A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-388.
2. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH: Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991;214:491-501.
3. Das Gupta TK: Results of treatment of 269 patients with primary cutaneous melanoma: A five-year prospective study. Ann Surg 1977;186:201-209.
4. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH: A prospective randomized study of the efficacy of routine elective lymph node lymphadenectomy in management of malignant melanoma: Preliminary results. Cancer 1978;41:948-956.
5. Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, et al.: Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-631.
6. Balch CM, Soong S-J, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al.: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-266.
7. Morton DL, Wen D-R, Wong JH, Economou JS, Cagle LA, Storm FK, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
8. Fee HJ, Robinson DS, Sample WF, Graham LS, Holmes EC, Morton DL: The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery 1978;84:626-632.
9. Morton DL, Wen D-R, Foshag LJ, Essner R, Cochran AJ: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
10. Essner R, Foshag LJ, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Presented at the Society of Surgical Oncology, Houston, TX: March 1994.
11. Morton DL, Wen D-R, Cochran AJ: Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait". Surg Oncol Clin North Am 1992;1:247-259.
12. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, et al.: Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-224.
13. Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, et al.: The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg 1996;22:715-720.
14. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al.: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-658.
15. Mudun A, Murray DR, Herda SC, Eshima D, Shattuck LA, Vansant JP, et al.: Early stage melanoma: Lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 1996;199:171-175.
16. Heller R, Becker J, Wasselle J, Baekey P, Cruse W, Wells K, et al.: Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg 1991;126:1455-1460.
17. Doi F, Chi DDJ, Charuworn BB, Conrad AJ, Russell J, Morton DL, Hoon DSB: Detection of β-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma. Int J Cancer 1996;65:454-459.
18. Wang X, Heller R, Van Voorhis N, Cruse CW, Glass F, Fenske N, et al.: Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-774.
19. Carson KF, Wen D-R, Li P-X, Lana AM-A, Bailly C, Morton DL, Cochran AJ: Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-840.
20. Reintgen D: Melanoma nodal metastases: biological significance and therapeutic considerations. Surg Oncol Clin North Am 1996; 5:105-120.
21. Hoon DSB, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, et al.: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995; 13:2109-2116.